General
Preferred name
ACEXAMIC ACID
Synonyms
Acexamic acid, calcium salt ()
6-Acetamidocaproic acid ()
acexamic-acid ()
Zinc acexamate ()
6-Acetamidohexanoic acid ()
NSC-12945 ()
CY-153 ()
Acide acexamique ()
CY 153 ()
.epsilon.-acetamidocaproic acid ()
Acido acexamico ()
Acexamate zinc ()
Zinc n-(acetylamino)-6-hexanoate ()
Copinal ()
.epsilon.-acetamidocaproic acid zinc salt ()
P&D ID
PD001097
CAS
57-08-9
70020-71-2
Tags
available
drug
drug candidate
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
6-Acetamidohexanoic acid is a metabolite of hexamethylene bisacetamide (HY-124284). 6-Acetamidohexanoic acid is less active than the parent compound HMBA and cannot induce cell differentiation[1][2][3].
PRICE
29
DESCRIPTION
6-Acetamidohexanoic acid is used in inhibiting the Gastrointestinal disease like gastric ulcer or small bowel inflammation. It is often used after some oral administration of ZAC(zinc acexamate), an antiulcer agent.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
6-Acetamidohexanoic acid (Acexamic Acid) is a kind of amino acids deriviate.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
14
BOC Sciences Bioactive Compounds
ChEMBL Drugs
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
42
Molecular Weight
173.11
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
6
Ring Count
0
Aromatic Ring Count
0
cLogP
0.77
TPSA
66.4
Fraction CSP3
0.75
Chiral centers
0.0
Largest ring
0.0
QED
0.58
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Amino Acids and Derivatives
COX
GAST
Drug intermediate
Drug Metabolite
Indication
wound healing
MOA
5 alpha reductase inhibitor
Pathway
Metabolic Enzyme/Protease
Immunology/Inflammation
Metabolism
Neuroscience
Solubility
DMSO: > 1.8 mg/mL
Source data
